Preoperative Enoxaparin Dosing for DVT Prophylaxis
For most surgical patients requiring preoperative DVT prophylaxis, administer enoxaparin 40 mg subcutaneously 2 hours before surgery 1. This is the FDA-approved dosing regimen for abdominal surgery patients at risk for thromboembolic complications.
Standard Dosing by Surgery Type
Abdominal Surgery
- 40 mg SC once daily, with initial dose given 2 hours prior to surgery 1
- Continue for 7-10 days postoperatively (up to 12 days studied in trials)
- This applies to patients undergoing abdominal or colorectal procedures at thromboembolic risk
Hip or Knee Replacement Surgery
You have two FDA-approved options 1:
Option 1 (Postoperative initiation):
- 30 mg SC every 12 hours
- Initial dose 12-24 hours after surgery (once hemostasis established)
- Continue 7-10 days (up to 14 days studied)
Option 2 (Preoperative initiation for hip replacement only):
- 40 mg SC once daily
- Initial dose 12 hours (±3 hours) before surgery
- Consider extended prophylaxis with 40 mg daily for 3 weeks post-discharge
Critical Timing Considerations
The 2-hour preoperative window for abdominal surgery is specifically chosen to balance efficacy and bleeding risk 1. Recent guidelines emphasize that for high-bleed-risk procedures, prophylactic-dose LMWH (enoxaparin 40 mg daily) should typically be started postoperatively rather than preoperatively—specifically the evening of the procedure—and continued 48-72 hours before restarting therapeutic anticoagulation if needed 2.
Dose Adjustments
Severe Renal Impairment (CrCl <30 mL/min)
- Reduce to 30 mg SC once daily for prophylaxis 1
- Monitor carefully for bleeding signs
Obesity
- Standard 40 mg daily dosing may be insufficient in patients with BMI ≥40 kg/m² 3
- Consider anti-Xa monitoring if available, targeting 0.2-0.4 units/mL
- Doses up to 0.57 mg/kg/day may be needed to achieve prophylactic levels 3
Underweight Patients (≤57 kg or BMI ≤18.5 kg/m²)
- Standard 40 mg daily appears safe and effective 4
- Dose reduction is not routinely necessary despite theoretical concerns
Key Clinical Pitfalls
Avoid these common errors:
Don't use prophylactic dosing preoperatively for high-bleed-risk procedures (neuraxial anesthesia, intracranial surgery, spinal procedures). Wait until postoperatively when hemostasis is confirmed 2.
Don't mix up the hip/knee dosing regimens. The 40 mg preoperative regimen was only studied for hip replacement, not knee replacement 1.
Don't forget the timing. The 2-hour preoperative window for abdominal surgery is specific—not "the night before" or "on call to OR" 1.
Avoid multiple-dose vials in pregnant patients when possible, as they contain benzyl alcohol preservative 1.
Postoperative Continuation
After high-bleed-risk procedures, prophylactic enoxaparin 40 mg daily can be started the evening of surgery and continued 48-72 hours before transitioning to therapeutic anticoagulation if indicated 2. For low-to-moderate bleed risk procedures, resumption can occur 24 hours postoperatively 5.
The evidence strongly supports that enoxaparin 40 mg once daily is as effective as unfractionated heparin three times daily for cancer surgery patients, with comparable safety profiles 6. Multiple trials across different surgical populations confirm the efficacy of this regimen initiated 2 hours preoperatively 7, 6, 8.